CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 16 Issue 1

Big Data, Personalised Medicine and Support for Healthcare Professionals

What Will Drive Pharma in 2024? In 2023, precision targeting for personalised medicines, improving the information flow between reps and healthcare professionals,...
Continue Reading →
Volume 16 Issue 1

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...
Continue Reading →
Volume 16 Issue 1

Transforming the Biologics Product Lifecycle with Inhalation Innovation

In recent years, the biopharmaceuticals landscape has witnessed a revolutionary shift with the emergence of new nasal inhalation technologies. Among these, soft mist...
Continue Reading →
Volume 16 Issue 1

Why is Real World Data the Key to Rare Disease Success?

The quest to understand and treat rare diseases is among the most challenging and vital missions in healthcare today. As the industry seeks innovative solutions, Rea...
Continue Reading →
Volume 16 Issue 1

Advancing Therapeutic Solutions with Antibody-drug Conjugates (ADCs)

As promising therapeutic agents for treating oncology indications, antibody-drug conjugates (ADCs) have become prominent in the biopharmaceutical market in recent ye...
Continue Reading →
Volume 16 Issue 1

Generative AI and its Impact on Speed to Market for Pharmaceuticals

Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced by months or even yea...
Continue Reading →
Volume 16 Issue 1

The End to Painfully Slow Cloud Migration?

Despite the benefits of moving to the cloud, migration can still be prohibitively time-consuming and costly, especially in a highly regulated industry like pharma. B...
Continue Reading →
Volume 16 Issue 1

Reaching the Marketplace

Understanding the Complexities of Paediatric Drug Development and Manufacturing Bringing a paediatric drug product to the marketplace can be very complex and also...
Continue Reading →
Volume 16 Issue 1

The Future of Sterility

Advancements and Innovations in Sterile Drug Product Manufacturing Sterile drug product manufacturing is complex and plays a crucial role in the pharmaceutical in...
Continue Reading →
Volume 16 Issue 1

The Key to Formulation Development is in the Details

During the tablet manufacturing process, tooling and press manufacturers are often faced with ongoing challenges. As a tooling and press manufacturer, you should be ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026